Tommy Tuberville sold Novo Nordisk A/S (NYSE: NVO)
Tommy Tuberville (R-AL), a U.S. Senator, has disclosed 1 trade in Novo Nordisk A/S (NVO) since 2024, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Tommy Tuberville sold $15,001 - $50,000 of Novo Nordisk A/S (NYSE: NVO) on January 19, 2024. Since that trade, NVO is down -48.07% against the S&P 500 up +55.37%, an outperformance of -103.43%.
Data updated
Tommy Tuberville's NVO trades vs the price
NVO is down -48.07% since Tommy Tuberville sold on January 19, 2024, versus +55.37% for the S&P 500.
Performance since this trade
All Tommy Tuberville NVO trades
Tommy Tuberville & NVO trading FAQ
Is it legal for Tommy Tuberville to trade Novo Nordisk A/S (NVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Tommy Tuberville sell NVO?
Tommy Tuberville disclosed a sale of $15,001 - $50,000 of Novo Nordisk A/S (NVO) on January 19, 2024, according to public STOCK Act filings.
How has NVO performed since Tommy Tuberville's trade?
Since Tommy Tuberville sold NVO on January 19, 2024, the stock is down -48.07%, versus +55.37% for the S&P 500 over the same period, an outperformance of -103.43%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVO trades?
Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.
Tommy Tuberville's NVO tradesAll congressional filings for Novo Nordisk A/STommy Tuberville's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.